Amid the COVID-19 crisis, the United States human vaccines market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period.
After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States human vaccines market are obtained with maximum precision.
This new 2022 market report provides a holistic analysis of the entire United States human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States’ human vaccines market. The report also provides up-to-date historical market size data for the period 2018 - 2021 and an illustrative forecast to 2028 covering key market aspects like market value, analysis, and trends for human vaccines in the United States. A comprehensive analysis has been done on market share with the percentage of all the 45 human vaccines brand used in the United States.
The report contains a deep analysis of the United States human vaccines market size in terms of value. The report provides a clear insight into current and future developments of the United States vaccines market. The report also explores the detailed analysis, insights of the top 45 vaccines market assessment in the United States from 2018 to 2021, and forecasts to 2028. The report also details the latest information about the vaccine’s pricing analysis, insights, and trends, and the regulatory framework of the United States human vaccines market.
The report also tracks and analyses competitive developments, including collaboration, partnership deals, distribution, exclusive and licensing agreements, new vaccine developments, and R&D activities in the market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.
The report also analyses detailed profiles of innovative and leading players with information on business overview, companies’ vaccines portfolio, promising vaccines in the clinical development, and the newest developments
The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.
1) Fluad
2) Trumenba
3) Deptacel
4) Quadracel
5) Kinrix
6) Pentacel
7) Vaxelis
8) IPOL
9) Vaqta
10) Havrix
11) Twinrix
12) Engerix
13) PedvaxHIB
14) ActHIB
15) Hiberix
16) MenQuadfi
17) Tenivac
18) Imovax
19) Prevnar 13
20) Gardasil 9
21) Menactra
22) Fluarix
23) FluLaval
24) Varivax
25) Proquad
26) M-M-R II
27) Adacel
28) Boostrix
29) Bexsero
30) Menveo
31) Shingrix
32) Rotateq
33) Rotarix
34) Infanrix
35) Pediarix
36) Heplisav-B
37) TDVAX
38) Biothrax
39) Recombivax HB
40) Pneumovax 23
41) FluMist Quadrivalent
42) Flucelvax Quadrivalent
43) Afluria Quadrivalent
44) Fluzone Quadrivalent
45) Flublok Quadrivalent
The prominent factors that are expected to contribute to the growth of the United States human vaccines market:
- Increased Disease Awareness
- Approval/launches of the New Vaccines
- Rising Focus on Immunization Programs
- Increasing Investments and Government Support for the Vaccines Development
After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States human vaccines market are obtained with maximum precision.
This new 2022 market report provides a holistic analysis of the entire United States human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States’ human vaccines market. The report also provides up-to-date historical market size data for the period 2018 - 2021 and an illustrative forecast to 2028 covering key market aspects like market value, analysis, and trends for human vaccines in the United States. A comprehensive analysis has been done on market share with the percentage of all the 45 human vaccines brand used in the United States.
The report contains a deep analysis of the United States human vaccines market size in terms of value. The report provides a clear insight into current and future developments of the United States vaccines market. The report also explores the detailed analysis, insights of the top 45 vaccines market assessment in the United States from 2018 to 2021, and forecasts to 2028. The report also details the latest information about the vaccine’s pricing analysis, insights, and trends, and the regulatory framework of the United States human vaccines market.
The report also tracks and analyses competitive developments, including collaboration, partnership deals, distribution, exclusive and licensing agreements, new vaccine developments, and R&D activities in the market. The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.
The report also analyses detailed profiles of innovative and leading players with information on business overview, companies’ vaccines portfolio, promising vaccines in the clinical development, and the newest developments
The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.
This Newest and Comprehensive the United States Human Vaccines Market Research Report 2022 Delivers:
- Comprehensive Research Methodology of the United States Human Vaccines Market
- Detailed and Extensive Market Overview with Key Analyst Insights
- Insights about Market Determinants that are Stimulating the United States Human Vaccines Market
- To Analyze the Historical Growth in the Market Size of the United States Human Vaccines Market from 2018 to 2021
- To Estimate and Forecast the Market Size of the United States Human Vaccines Market from 2022 to 2028 and Growth Rate until 2028
- Detailed Insights of the Top 45 Human Vaccines Market Value Used in the U.S. with Six Years Forecast
- An Insightful Analysis of the Top 45 Vaccines Brand Market Share and Y-o-Y Growth Rate
- Delivers All-inclusive Insights on the Latest Pricing Analysis, Insights, and Trends
- Delivers an In-Depth Analysis of Evolving Market Trends, Drivers, and Restraints of the United States Human Vaccines Market
- An Insightful Investigation has been done on Promising Human Vaccines in the Clinical Development
- Delivers Comprehensive Insights into the Regulatory Framework of the United States Human Vaccines Market
- Tracks Competitive Developments, Approaches, Recent Industry Developments, Partnership, Collaboration Deals, Distribution, Exclusive, and Licensing Agreement
- A Comprehensive List of the Leading Companies along with the Analysis of their Current Vaccines Portfolio, Promising Human Vaccines in the Clinical Development, and Present Development
The Key Market Players for the United States Human Vaccines Market are Listed Below:
- Pfizer
- Merck
- Sanofi Pasteur
- Seqirus (CSL Limited)
- AstraZeneca
- GlaxoSmithKline (GSK)
- Emergent Biosolutions
- Dynavax Technologies Corporation
The Following 45 Leading Human Vaccines Brand are Detailed with Market Value and Six-Years Forecast:
1) Fluad
2) Trumenba
3) Deptacel
4) Quadracel
5) Kinrix
6) Pentacel
7) Vaxelis
8) IPOL
9) Vaqta
10) Havrix
11) Twinrix
12) Engerix
13) PedvaxHIB
14) ActHIB
15) Hiberix
16) MenQuadfi
17) Tenivac
18) Imovax
19) Prevnar 13
20) Gardasil 9
21) Menactra
22) Fluarix
23) FluLaval
24) Varivax
25) Proquad
26) M-M-R II
27) Adacel
28) Boostrix
29) Bexsero
30) Menveo
31) Shingrix
32) Rotateq
33) Rotarix
34) Infanrix
35) Pediarix
36) Heplisav-B
37) TDVAX
38) Biothrax
39) Recombivax HB
40) Pneumovax 23
41) FluMist Quadrivalent
42) Flucelvax Quadrivalent
43) Afluria Quadrivalent
44) Fluzone Quadrivalent
45) Flublok Quadrivalent
The Report Helps Answer the Following Questions:
- What is the current scenario of the United States human vaccines market?
- What is the total market size and forecast (until 2028) of the United States human vaccines market?
- How big is the United States human vaccines market?
- At what CAGR is the U.S. human vaccines market projected to grow in the forecast period (2022-2028)?
- What are the leading human vaccines? What are their revenue potentials to 2028?
- Which human vaccine brand provides the highest market share?
- What is the regulatory framework in the United States vaccines market?
- What are the key factors driving the United States human vaccines market?
- What are the key challenges of the United States human vaccines market?
- What are the major deals and agreement happenings in the United States human vaccines market?
- What are the United States human vaccines pricing trends and analysis?
- What are the various human vaccines available in the United States?
- Who are the topmost market players? What are their happenings, current developments, and scenarios?
- How is the market predicted to develop in the future?
Table of Contents
1. Executive Summary2. United States Human Vaccines Market Size and Forecast (2018 - 2028)3. United States Human Vaccines Brand Market Share and Y-o-Y Growth (%), 2018 - 20286. United States Human Vaccines Pricing Analysis, Insights and Trends7. Regulatory Framework of the United States Human Vaccines Market
4. Key Market Growth Drivers and Challenges in the United States Human Vaccines Market
5. United States Top 45 Human Vaccines Market Value Analysis, Insights and Forecasts, 2018 - 2028
8. Major Deals and Agreement Happenings in the Human Vaccines Market
9. Leading Companies in the United States Human Vaccines Market
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned
- AstraZeneca
- Dynavax Technologies Corporation
- Emergent Biosolutions
- GlaxoSmithKline (GSK)
- Merck
- Pfizer
- Sanofi Pasteur
- Seqirus (CSL Limited)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 215 |
| Published | June 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 21545 Million |
| Forecasted Market Value ( USD | $ 31517 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
